RXO, Inc.
RXO
$19.19
-$0.62-3.13%
| Weiss Ratings | RXO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | D+ | |||
| Rating Factors | RXO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | RXO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.00 | |||
| Price History | RXO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -3.62% | |||
| 30-Day Total Return | -25.79% | |||
| 60-Day Total Return | -32.95% | |||
| 90-Day Total Return | -31.85% | |||
| Year to Date Total Return | -18.93% | |||
| 1-Year Total Return | -8.23% | |||
| 2-Year Total Return | -7.12% | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -39.64% | |||
| 52-Week Low % Change | 5.65% | |||
| Price | RXO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $32.82 | |||
| 52-Week Low Price | $18.75 | |||
| 52-Week Low Price (Date) | Apr 30, 2024 | |||
| 52-Week High Price (Date) | Jul 31, 2024 | |||
| Valuation | RXO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.24B | |||
| Enterprise Value | 3.86B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -2.15 | |||
| Earnings Per Share Growth | 21,883.67% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.72 | |||
| Price/Book (Q) | 2.00 | |||
| Enterprise Value/Revenue (TTM) | 0.85 | |||
| Price | $19.19 | |||
| Enterprise Value/EBITDA (TTM) | 33.03 | |||
| Enterprise Value/EBIT | 128.82 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | RXO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 164.41M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | RXO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 980 308 6058 | |||
| Address | 11215 North Community House Road Charlotte, NC 28277 | |||
| Website | www.rxo.com | |||
| Country | United States | |||
| Year Founded | 2022 | |||
| Profitability | RXO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 0.65% | |||
| Profit Margin | -6.37% | |||
| Management Effectiveness | RXO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 0.72% | |||
| Return on Equity | -- | |||
| Income Statement | RXO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 4.55B | |||
| Total Revenue (TTM) | 4.55B | |||
| Revenue Per Share | $27.68 | |||
| Gross Profit (TTM) | 783.00M | |||
| EBITDA (TTM) | 117.00M | |||
| EBIT (TTM) | 30.00M | |||
| Net Income (TTM) | -290.00M | |||
| Net Income Avl. to Common (TTM) | -290.00M | |||
| Total Revenue Growth (Q YOY) | 70.45% | |||
| Earnings Growth (Q YOY) | -1,350.00% | |||
| EPS Diluted (TTM) | -2.15 | |||
| EPS Diluted Growth (Q YOY) | -1,623.00% | |||
| Balance Sheet | RXO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 35.00M | |||
| Cash Per Share (Q) | $0.21 | |||
| Total Current Assets (Q) | 1.34B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.61B | |||
| Current Ratio (Q) | 1.257 | |||
| Book Value Per Share (Q) | $9.92 | |||
| Total Assets (Q) | 3.41B | |||
| Total Current Liabilities (Q) | 1.07B | |||
| Total Debt (Q) | 664.00M | |||
| Total Liabilities (Q) | 1.80B | |||
| Total Common Equity (Q) | 1.61B | |||
| Cash Flow | RXO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.06B | |||
| Cash from Financing (TTM) | 1.11B | |||
| Net Change in Cash (TTM) | 30.00M | |||
| Levered Free Cash Flow (TTM) | -119.00M | |||
| Cash from Operations (TTM) | -12.00M | |||
